This study demonstrates the feasibility of using UCNPs as a promisingcandidate for high contrast breast cancer tissue labeling and brings upthe potential for quantification of HER2 expression as opposed to standardDAB labeling. This evidence concerns the gene ERBB2 and breast cancer.